Zhitong Finance App News, Haiwang Biotech (000078.SZ) announced that Grant Thornton Accounting Firm (Special General Partnership) issued an internal control audit report with a negative opinion on the company's internal control in 2025. According to section 9.4.1 (6) of the “Shenzhen Stock Exchange Stock Listing Rules”, if the internal control of the company's financial report for the next year is issued an audit report that cannot express an opinion or negative opinion, the company's shares will be subject to a delisting risk warning.

Furthermore, trading of the company's shares will be suspended for 1 day on April 30, 2026, and other risk warnings (ST) will be implemented after the resumption of trading.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.